Evidence map›Paper›PMID 40406472›Full record

ArticleRevista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia2025

Follow-up of women after gynecological cancer treatment.

Agnaldo Lopes da Silva, Mariana Seabra Leite Praça, Matheus Eduardo Soares Pinhati, Laura Guimarães Castro, Renato Moretti-Marques, Angélica Nogueira-Rodrigues, Eduardo Batista Cândido

Abstract read
In one paragraph

Article in Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Comments on: Follow-up of women after gynecological cancer treatment.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agnaldo Lopes da SilvaFaculdade de Medicina Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.ORCID https://orcid.org/0000-0003-2527-3729
Mariana Seabra Leite PraçaFaculdade de Medicina Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.ORCID https://orcid.org/0000-0002-9249-0312
Matheus Eduardo Soares PinhatiFaculdade de Medicina Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.ORCID https://orcid.org/0000-0003-1014-1555
Laura Guimarães CastroFaculdade de Medicina Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.ORCID https://orcid.org/0000-0002-8695-0669
Renato Moretti-MarquesHospital Israelita Albert Einstein São PauloSP Brazil Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID https://orcid.org/0000-0003-3049-7727
Angélica Nogueira-RodriguesFaculdade de Medicina Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.ORCID https://orcid.org/0000-0002-3901-3832
Eduardo Batista CândidoFaculdade de Medicina Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.ORCID https://orcid.org/0000-0002-5261-5563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•The population of female cancer survivors has increased over the last few years, highlighting the importance of appropriate follow-up of these patients. •The main objective of long-term follow-up for patients treated for cancer is the early detection of recurrences, whether local, lymph node or distant metastases. •Symptom assessment and physical examination play an important role in the follow-up of patients treated for gynecological neoplasms. •The use of laboratory or imaging tests to detect recurrence in asymptomatic patients should be based on evidence that it improves survival or provides less morbid treatments, also considering cost and availability.

Indexed as

AftercareGenital Neoplasms, FemaleNeoplasm Recurrence, LocalCancer SurvivorsFemaleFollow-Up StudiesHumans

Identifiers

PMID40406472
PMCPMC12097441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.